Status:
COMPLETED
Intravitreal Bevacizumab and Low Fluence Photodynamic Therapy
Lead Sponsor:
University of Campania Luigi Vanvitelli
Conditions:
Myopia
Eligibility:
All Genders
35-60 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to report the treatment effect and safety of combined intravitreal bevacizumab (IVB) and photodynamic therapy (PDT) with verteporfin using a reduced (RF) light fluence rat...
Detailed Description
In this retrospective interventional case series, 16 patients with myopic CNV were included. All patients were treated with 1.25 mg of intravitreal bevacizumab followed by RF-PDT (25 J/cm²), 2 days la...
Eligibility Criteria
Inclusion
- Myopic CNV, CNV leakage
Exclusion
- CNV not associated with high myopia
- No activity of CNV
Key Trial Info
Start Date :
November 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2009
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT00802126
Start Date
November 1 2007
End Date
May 1 2009
Last Update
February 8 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ophthalmology Department SUN
Napoli, Napoli, Italy, 80100